Title |
Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe
|
---|---|
Published in |
Parasites & Vectors, February 2015
|
DOI | 10.1186/s13071-015-0649-0 |
Pubmed ID | |
Authors |
Ángel Sainz, Xavier Roura, Guadalupe Miró, Agustín Estrada-Peña, Barbara Kohn, Shimon Harrus, Laia Solano-Gallego |
Abstract |
Canine ehrlichiosis and anaplasmosis are important tick-borne diseases with a worldwide distribution. Information has been continuously collected on these infections in Europe, and publications have increased in recent years. Prevalence rates are high for Ehrlichia and Anaplasma spp. infections in dogs from different European countries. The goal of this article was to provide a practical guideline for veterinary practitioners on the diagnosis, treatment, and prevention of ehrlichiosis and anaplasmosis in dogs from Europe. This guideline is intended to answer the most common questions on these diseases from a practical point of view. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 1 | 10% |
United States | 1 | 10% |
United Kingdom | 1 | 10% |
Spain | 1 | 10% |
Unknown | 6 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 90% |
Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | <1% |
Brazil | 2 | <1% |
Portugal | 1 | <1% |
Unknown | 486 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 75 | 15% |
Student > Bachelor | 58 | 12% |
Researcher | 49 | 10% |
Student > Ph. D. Student | 32 | 7% |
Other | 31 | 6% |
Other | 107 | 22% |
Unknown | 139 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Veterinary Science and Veterinary Medicine | 187 | 38% |
Agricultural and Biological Sciences | 57 | 12% |
Medicine and Dentistry | 45 | 9% |
Biochemistry, Genetics and Molecular Biology | 14 | 3% |
Immunology and Microbiology | 10 | 2% |
Other | 26 | 5% |
Unknown | 152 | 31% |